BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio

Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...

November 19, 2025 | News

Volta Labs Expands Callisto Automation Through Strategic Partnership with New England Biolabs

Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents,&nb...

November 17, 2025 | News

LISCure Biosciences Secures Fourth Global Evaluation Partner for Its Next Generation BBB Shuttle Platform ExoPN 101

LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Materi...

November 14, 2025 | News

Strategic Transaction Positions Crown Bioscience for Global Expansion in Translational Oncology

Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology JSR Life Sciences, a global leader in life sci...

November 14, 2025 | News

Teijin and BioVaram Form Strategic Alliance To Advance Regenerative Medicine and Implantable Medical Technologies Across Japan and India

Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), announced today ...

November 13, 2025 | News

Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...

November 13, 2025 | News

Samsung Epis Holdings Launches Epis NexLab to Advance Next-Generation Biotechnology Platforms

Samsung Epis Holdings Co., Ltd. announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development o...

November 12, 2025 | News

OGT Launches SureSeq™ Myeloid MRD Plus NGS Panel to Enhance Detection of Residual Disease in AML

OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Pa...

November 11, 2025 | News

Muna Therapeutics Doses First Subjects in Phase 1 Trial of TREM2 Agonist MNA-001 for Alzheimer’s Disease

MNA-001 has best-in-class potential based on preclinical data demonstrating ability to significantly reduce neurotoxic amyloid burden and reprogram microgl...

November 11, 2025 | News

ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...

November 11, 2025 | News

Harbour BioMed and Evinova Partner to Drive AI-Enabled Biologics Development

Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel anti...

November 10, 2025 | News

AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer

First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO...

November 05, 2025 | News

Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics

Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...

November 04, 2025 | News

NovaBridge Subsidiary Visara Assigns Exclusive License for VIS-101 to Everest Medicines to Advance Treatment for Wet AMD Across Asia

NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet...

November 03, 2025 | News

Stay Connected